The United States Insulin Syringes Market is set to surpass US$ 1 Billion by 2027.
This new market report presents a comprehensive study of the entire U.S. insulin syringes market. The report offers the most up–to–date industry data on the actual market situation and future outlook for the U.S. insulin syringes market. The report also provides up–to–date market size data for the historical period 2019 – 2020 and an illustrative forecast to 2027 covering key market aspects like market value, volume, and pricing analysis for insulin syringes.
This Comprehensive Market Research Report Provides:
• To Analyse the Historical Growth in the Market Size of the United States Insulin Syringes Market from 2019 to 2020
• To Estimate and Forecast the Market Size of the United States Insulin Syringes from 2021 to 2027 and Growth Rate until 2027
• Detailed Assessment of the United States Insulin Syringes Users Volume and Forecast to 2027
• Delivers Comprehensive Insights on the Recent Development and Affairs in the Insulin Syringes Industry
• An Insightful Analysis of the United States Diabetes Population and Forecast to 2027
• Delivers a Complete Overview of the United States Insulin Users and Forecast to 2027
• Detailed Insights into the Regulatory Framework of the United States Insulin Syringes Market
• Features Reimbursement Patterns of the United States Insulin Syringes Market
• Delivers an In-Depth Analysis of Evolving Market Trends, Drivers and Restraints of the United States Insulin Syringes Market
• A Comprehensive List of the Key Players Along with the Analysis of their Current Product Portfolios, Business Overview, and Recent Development
The Leading Companies for the United States Insulin Syringes Market are Listed Below:
• Arkray, Inc
• UltiMed, Inc
• Allison Medical, Inc
• Cardinal Health, Inc
• Abbott Diabetes Care
• Smiths Medical, Inc.
• Eli Lilly and Company
• Trividia Health, Inc
• MHC Medical Products, LLC
• Home Aide Diagnostics, Inc
• Retractable Technologies, Inc.
• Prodigy Diabetes Care, LLC
• AdvaCare Pharma USA, LLC
• Becton, Dickinson, and Company (BD)
• Advocate Meters (Pharma Supply, Inc.)
Key Questions Addressed by the Report
• What is the current size of the overall insulin syringes market in the United States?
• How much will this market be worth from 2021 to 2027?
• How big is the United States insulin syringes market?
• How much do insulin syringes cost?
• What are the key marketed insulin syringes devices available in the United States?
• What are the major drivers of the United States insulin syringes market?
• What are the major challenges of the United States insulin syringes market?
• What is the reimbursement pattern in the United States insulin syringes market?
• What is the regulatory framework in the United States insulin syringes market?
• Which companies make insulin syringes?
• Who are the top market players? What are their happenings, current developments, and scenarios?
'
1. Executive Summary
2. United States Diabetes Population and Forecast, 2019 – 2027
3. United States Insulin Users Volume and Forecast, 2019 – 2027
4. United States Insulin Syringe Users Volume Assessment and Forecast, 2019 – 2027
5. United States Insulin Syringe Market Analysis, Insights and Forecast, 2019 – 2027
6. Key Market Growth Drivers and Challenges of the United States Insulin Syringe Market
6.1 Market Growth Drivers
6.2 Market Challenges
7. Reimbursement Environment of the United States Insulin Syringe Market
8. Regulatory Framework of the United States Insulin Syringe Market
9. Key Companies Profiles (Overview and Key Marketed Products)
9.1 Becton, Dickinson, and Company (BD)
9.2 Abbott Diabetes Care
9.3 Smith’s Medical, Inc.
9.4 Eli Lilly and Company
9.5 Arkray, Inc
9.6 Trividia Health, Inc
9.7 MHC Medical Products, LLC
9.8 Home Aide Diagnostics, Inc
9.9 Advocate Meters (Pharma Supply, Inc.)
9.10 Retractable Technologies, Inc.
9.11 Prodigy Diabetes Care, LLC
9.12 UltiMed, Inc
9.13 AdvaCare Pharma USA, LLC
9.14 Allison Medical, Inc
9.15 Cardinal Health, Inc
List of Tables:
Table 6–1: Worldwide Healthcare Spending on Diabetes (Billion US$), 2015 & 2040
List of Figures:
Figure 2–1: United States Diabetes Population (Thousand), 2019 – 2020
Figure 2–2: United States Diabetes Population Forecast (Thousand), 2021 – 2027
Figure 3–1: United States Insulin Users (Thousand),2019 – 2020
Figure 3–2: United States Insulin Users Forecast (Thousand),2021 – 2027
Figure 4–1: United States Insulin Syringe Users Volume Assessment (Thousand), 2019 – 2020
Figure 4–2: United States Insulin Syringe Users Volume Assessment Forecast (Thousand), 2021 – 2027
Figure 5–1: United States Insulin Syringe Market (Million US$), 2019 – 2020
Figure 5–2: United States Insulin Syringe Market Forecast (Million US$), 2021 – 2027
